Should Medicare Regulate The Price Of Prescription Drugs?

Source: Journal of Policy Analysis and Management, Early View, August 11, 2016
(subscription required)

Articles include:
The Advantages Of Awarding The Federal Government Negotiating Power Over The Prices Of Prescription Drugs
Rena M. Conti

Awarding federal government negotiating power over the prices of prescription drugs for Medicare and Medicaid beneficiaries offers some substantial advantages. Yet, in practice, strongly opposed rhetoric stemming from many actors who profit off the current system may trump its strengths. “Second best” policies with great hope to rein in prescription drug prices are already gaining a foothold in the national debate and should be considered by policymakers looking to rein in prices for Medicare and Medicaid beneficiaries, One entails the use of performance contracting on price for selected drugs between pharmaceutical manufacturers and insurers. The other entails carving out the financing of selected drugs or drug classes with substantial public health import to the federal government.

Why Medicare Price Negotiation Is The Wrong Prescription For Rising Drug Spending
Geoffrey F. Joyce And Neeraj Sood

Why Medicare Price Negotiation Is The Wrong Prescription For Rising Drug Spending: Response To Rena Conti
Geoffrey F. Joyce And Neeraj Sood

Response to Joyce and Soon
Rena M. Conti

Should Medicare Regulate The Price Of Prescription Drugs?